Magic mushroom therapy tested to soothe cancer Patients' fears
NCT ID NCT05847686
Summary
This study tested whether a pharmaceutical-grade form of psilocybin, the active compound in 'magic mushrooms,' given alongside group and individual therapy, is safe and helpful for reducing anxiety and depression in people with advanced, incurable cancer. It involved 55 adult participants with metastatic cancer who were experiencing significant distress. The main goal was to see if this combined approach could safely ease the emotional burden of a serious illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.